SCHEMBL25224397

SCHEMBL25224397

COC(=O)C1COCC(Nc2ncc(C(F)(F)F)c(OC3COC3)n2)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 5/20 0.40
KDR P35968 1/20 0.40
LRRK2 Q5S007 5/20 0.40
PTK2 Q05397 2/20 0.38
HSD11B1 P28845 2/20 0.38
ULK1 O75385 1/20 0.37
ATXN2 Q99700 1/20 0.36
CCNE1 P24864 4/20 0.36
CCNK O75909 3/20 0.36
CDK12 Q9NYV4 3/20 0.36
CDK7 P50613 2/20 0.36
CCNH P51946 2/20 0.36
MNAT1 P51948 2/20 0.36
CCNT1 O60563 2/20 0.36
CDK9 P50750 2/20 0.36
MAPK3 P27361 2/20 0.36
MAPK1 P28482 1/20 0.35
MAPK8 P45983 1/20 0.35
MAPK9 P45984 1/20 0.35
CDK1 P06493 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30397298 1.00 CDK2 (0.40) CDK2KDRLRRK2PTK2HSD11B1
SCHEMBL25218005 0.90 CDK2 (0.41) CDK2KDRLRRK2PTK2HSD11B1
SCHEMBL30397931 0.90 CDK2 (0.41) CDK2KDRLRRK2PTK2HSD11B1
SCHEMBL22998319 0.81 ULK1 (0.44) CDK2KDRPTK2HSD11B1ULK1
SCHEMBL30397130 0.81 MAPK3 (0.46) CDK2KDRLRRK2PTK2HSD11B1
SCHEMBL30397992 0.81 MAPK3 (0.46) CDK2KDRLRRK2PTK2HSD11B1
SCHEMBL25209416 0.80 GRM5 (0.38) CDK2KDRPTK2ULK1ATXN2
SCHEMBL30397703 0.80 GRM5 (0.38) CDK2KDRPTK2ULK1ATXN2
SCHEMBL25522696 0.78 ULK1 (0.55) CDK2KDRPTK2ULK1CCNE1
SCHEMBL28486909 0.78 ULK1 (0.42) CDK2KDRULK1MAPK3MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023091726-A1 INHIBITORS OF CYCLIN‑DEPENDENT KINASE 12 (CDK12) SYROS PHARMACEUTICALS, INC. (US) 2023-05-25 WO disclosed
WO-2023091726-A1 INHIBITORS OF CYCLIN‑DEPENDENT KINASE 12 (CDK12) SYROS PHARMACEUTICALS, INC. (US) 2023-05-25 WO disclosed